Cargando…

Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients

INTRODUCTION: The eye offers potential for the diagnosis of Alzheimer’s disease (AD) with retinal imaging techniques being explored to quantify amyloid accumulation and aspects of neurodegeneration. To assess these changes, this proof-of-concept study combined hyperspectral imaging and optical coher...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemmens, Sophie, Van Craenendonck, Toon, Van Eijgen, Jan, De Groef, Lies, Bruffaerts, Rose, de Jesus, Danilo Andrade, Charle, Wouter, Jayapala, Murali, Sunaric-Mégevand, Gordana, Standaert, Arnout, Theunis, Jan, Van Keer, Karel, Vandenbulcke, Mathieu, Moons, Lieve, Vandenberghe, Rik, De Boever, Patrick, Stalmans, Ingeborg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654576/
https://www.ncbi.nlm.nih.gov/pubmed/33172499
http://dx.doi.org/10.1186/s13195-020-00715-1
_version_ 1783608094797856768
author Lemmens, Sophie
Van Craenendonck, Toon
Van Eijgen, Jan
De Groef, Lies
Bruffaerts, Rose
de Jesus, Danilo Andrade
Charle, Wouter
Jayapala, Murali
Sunaric-Mégevand, Gordana
Standaert, Arnout
Theunis, Jan
Van Keer, Karel
Vandenbulcke, Mathieu
Moons, Lieve
Vandenberghe, Rik
De Boever, Patrick
Stalmans, Ingeborg
author_facet Lemmens, Sophie
Van Craenendonck, Toon
Van Eijgen, Jan
De Groef, Lies
Bruffaerts, Rose
de Jesus, Danilo Andrade
Charle, Wouter
Jayapala, Murali
Sunaric-Mégevand, Gordana
Standaert, Arnout
Theunis, Jan
Van Keer, Karel
Vandenbulcke, Mathieu
Moons, Lieve
Vandenberghe, Rik
De Boever, Patrick
Stalmans, Ingeborg
author_sort Lemmens, Sophie
collection PubMed
description INTRODUCTION: The eye offers potential for the diagnosis of Alzheimer’s disease (AD) with retinal imaging techniques being explored to quantify amyloid accumulation and aspects of neurodegeneration. To assess these changes, this proof-of-concept study combined hyperspectral imaging and optical coherence tomography to build a classification model to differentiate between AD patients and controls. METHODS: In a memory clinic setting, patients with a diagnosis of clinically probable AD (n = 10) or biomarker-proven AD (n = 7) and controls (n = 22) underwent non-invasive retinal imaging with an easy-to-use hyperspectral snapshot camera that collects information from 16 spectral bands (460–620 nm, 10-nm bandwidth) in one capture. The individuals were also imaged using optical coherence tomography for assessing retinal nerve fiber layer thickness (RNFL). Dedicated image preprocessing analysis was followed by machine learning to discriminate between both groups. RESULTS: Hyperspectral data and retinal nerve fiber layer thickness data were used in a linear discriminant classification model to discriminate between AD patients and controls. Nested leave-one-out cross-validation resulted in a fair accuracy, providing an area under the receiver operating characteristic curve of 0.74 (95% confidence interval [0.60–0.89]). Inner loop results showed that the inclusion of the RNFL features resulted in an improvement of the area under the receiver operating characteristic curve: for the most informative region assessed, the average area under the receiver operating characteristic curve was 0.70 (95% confidence interval [0.55, 0.86]) and 0.79 (95% confidence interval [0.65, 0.93]), respectively. The robust statistics used in this study reduces the risk of overfitting and partly compensates for the limited sample size. CONCLUSIONS: This study in a memory-clinic-based cohort supports the potential of hyperspectral imaging and suggests an added value of combining retinal imaging modalities. Standardization and longitudinal data on fully amyloid-phenotyped cohorts are required to elucidate the relationship between retinal structure and cognitive function and to evaluate the robustness of the classification model.
format Online
Article
Text
id pubmed-7654576
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76545762020-11-12 Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients Lemmens, Sophie Van Craenendonck, Toon Van Eijgen, Jan De Groef, Lies Bruffaerts, Rose de Jesus, Danilo Andrade Charle, Wouter Jayapala, Murali Sunaric-Mégevand, Gordana Standaert, Arnout Theunis, Jan Van Keer, Karel Vandenbulcke, Mathieu Moons, Lieve Vandenberghe, Rik De Boever, Patrick Stalmans, Ingeborg Alzheimers Res Ther Research INTRODUCTION: The eye offers potential for the diagnosis of Alzheimer’s disease (AD) with retinal imaging techniques being explored to quantify amyloid accumulation and aspects of neurodegeneration. To assess these changes, this proof-of-concept study combined hyperspectral imaging and optical coherence tomography to build a classification model to differentiate between AD patients and controls. METHODS: In a memory clinic setting, patients with a diagnosis of clinically probable AD (n = 10) or biomarker-proven AD (n = 7) and controls (n = 22) underwent non-invasive retinal imaging with an easy-to-use hyperspectral snapshot camera that collects information from 16 spectral bands (460–620 nm, 10-nm bandwidth) in one capture. The individuals were also imaged using optical coherence tomography for assessing retinal nerve fiber layer thickness (RNFL). Dedicated image preprocessing analysis was followed by machine learning to discriminate between both groups. RESULTS: Hyperspectral data and retinal nerve fiber layer thickness data were used in a linear discriminant classification model to discriminate between AD patients and controls. Nested leave-one-out cross-validation resulted in a fair accuracy, providing an area under the receiver operating characteristic curve of 0.74 (95% confidence interval [0.60–0.89]). Inner loop results showed that the inclusion of the RNFL features resulted in an improvement of the area under the receiver operating characteristic curve: for the most informative region assessed, the average area under the receiver operating characteristic curve was 0.70 (95% confidence interval [0.55, 0.86]) and 0.79 (95% confidence interval [0.65, 0.93]), respectively. The robust statistics used in this study reduces the risk of overfitting and partly compensates for the limited sample size. CONCLUSIONS: This study in a memory-clinic-based cohort supports the potential of hyperspectral imaging and suggests an added value of combining retinal imaging modalities. Standardization and longitudinal data on fully amyloid-phenotyped cohorts are required to elucidate the relationship between retinal structure and cognitive function and to evaluate the robustness of the classification model. BioMed Central 2020-11-10 /pmc/articles/PMC7654576/ /pubmed/33172499 http://dx.doi.org/10.1186/s13195-020-00715-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lemmens, Sophie
Van Craenendonck, Toon
Van Eijgen, Jan
De Groef, Lies
Bruffaerts, Rose
de Jesus, Danilo Andrade
Charle, Wouter
Jayapala, Murali
Sunaric-Mégevand, Gordana
Standaert, Arnout
Theunis, Jan
Van Keer, Karel
Vandenbulcke, Mathieu
Moons, Lieve
Vandenberghe, Rik
De Boever, Patrick
Stalmans, Ingeborg
Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
title Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
title_full Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
title_fullStr Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
title_full_unstemmed Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
title_short Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients
title_sort combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify alzheimer’s disease patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654576/
https://www.ncbi.nlm.nih.gov/pubmed/33172499
http://dx.doi.org/10.1186/s13195-020-00715-1
work_keys_str_mv AT lemmenssophie combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT vancraenendoncktoon combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT vaneijgenjan combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT degroeflies combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT bruffaertsrose combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT dejesusdaniloandrade combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT charlewouter combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT jayapalamurali combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT sunaricmegevandgordana combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT standaertarnout combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT theunisjan combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT vankeerkarel combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT vandenbulckemathieu combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT moonslieve combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT vandenbergherik combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT deboeverpatrick combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients
AT stalmansingeborg combinationofsnapshothyperspectralretinalimagingandopticalcoherencetomographytoidentifyalzheimersdiseasepatients